675 related articles for article (PubMed ID: 17315858)
1. Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.
Kowol CR; Berger R; Eichinger R; Roller A; Jakupec MA; Schmidt PP; Arion VB; Keppler BK
J Med Chem; 2007 Mar; 50(6):1254-65. PubMed ID: 17315858
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterisation and cytotoxic properties of the N1,N4-diarylidene-S-methyl-thiosemicarbazone chelates with Fe(III) and Ni(II).
Bal T; Atasever B; Solakoğlu Z; Erdem-Kuruca S; Ulküseven B
Eur J Med Chem; 2007 Feb; 42(2):161-7. PubMed ID: 17070966
[TBL] [Abstract][Full Text] [Related]
3. Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.
Kowol CR; Trondl R; Heffeter P; Arion VB; Jakupec MA; Roller A; Galanski MS; Berger W; Keppler BK
J Med Chem; 2009 Aug; 52(16):5032-43. PubMed ID: 19637923
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
[TBL] [Abstract][Full Text] [Related]
5. An electrochemical study of antineoplastic gallium, iron and ruthenium complexes with redox noninnocent alpha-N-heterocyclic chalcogensemicarbazones.
Kowol CR; Reisner E; Chiorescu I; Arion VB; Galanski MS; Deubel DV; Keppler BK
Inorg Chem; 2008 Dec; 47(23):11032-47. PubMed ID: 18973290
[TBL] [Abstract][Full Text] [Related]
6. Mn(II), Co(II) and Zn(II) complexes with heterocyclic substituted thiosemicarbazones: synthesis, characterization, X-ray crystal structures and antitumor comparison.
Li MX; Chen CL; Zhang D; Niu JY; Ji BS
Eur J Med Chem; 2010 Jul; 45(7):3169-77. PubMed ID: 20434816
[TBL] [Abstract][Full Text] [Related]
7. Nickel (II) complexes of naphthaquinone thiosemicarbazone and semicarbazone: synthesis, structure, spectroscopy, and biological activity.
Afrasiabi Z; Sinn E; Lin W; Ma Y; Campana C; Padhye S
J Inorg Biochem; 2005 Jul; 99(7):1526-31. PubMed ID: 15927263
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and structure-activity relationships of four alpha-N-heterocyclic thiosemicarbazone derivatives crystal structure of 2-acetylpyrazine thiosemicarbazone.
Li MX; Chen CL; Ling CS; Zhou J; Ji BS; Wu YJ; Niu JY
Bioorg Med Chem Lett; 2009 May; 19(10):2704-6. PubMed ID: 19369075
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine (4)N-dimethylthiosemicarbazone.
Arion VB; Jakupec MA; Galanski MS; Unfried P; Keppler BK
J Inorg Biochem; 2002 Jul; 91(1):298-305. PubMed ID: 12121788
[TBL] [Abstract][Full Text] [Related]
10. Effect of metal ion complexation and chalcogen donor identity on the antiproliferative activity of 2-acetylpyridine N,N-dimethyl(chalcogen)semicarbazones.
Kowol CR; Eichinger R; Jakupec MA; Galanski MS; Arion VB; Keppler BK
J Inorg Biochem; 2007 Nov; 101(11-12):1946-57. PubMed ID: 17825917
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
[TBL] [Abstract][Full Text] [Related]
12. Novel 1D chain Fe(III)-salen-like complexes involving anionic heterocyclic N-donor ligands. Synthesis, X-ray structure, magnetic, (57)Fe Mössbauer, and biological activity studies.
Herchel R; Sindelár Z; Trávnícek Z; Zboril R; Vanco J
Dalton Trans; 2009 Nov; (44):9870-80. PubMed ID: 19885536
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
14. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
[TBL] [Abstract][Full Text] [Related]
15. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.
Kostova I; Momekov G; Zaharieva M; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):542-51. PubMed ID: 15922838
[TBL] [Abstract][Full Text] [Related]
17. Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity.
Casas JS; Castaño MV; Cifuentes MC; García-Monteagudo JC; Sánchez A; Sordo J; Abram U
J Inorg Biochem; 2004 Jun; 98(6):1009-16. PubMed ID: 15149809
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
[TBL] [Abstract][Full Text] [Related]
19. Chelating agents as potential antitumorals: alpha-(N)-heterocyclic hydrazones and bis-alpha-(N)-heterocyclic hydrazones.
Savini L; Massarelli P; Chiasserini L; Nencini C; Pellerano C
Farmaco; 1997 Oct; 52(10):609-13. PubMed ID: 9507672
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-alpha-amino acid conjugates.
Wang ZM; Lin HK; Zhu SR; Liu TF; Zhou ZF; Chen YT
Anticancer Drug Des; 2000 Dec; 15(6):405-11. PubMed ID: 11716433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
